Rize Oncology Inc. (CSE:RIZE)

Rize Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.16	1.36	1.8	0.18	0.05
Cash & Short-Term Investments	1.16	1.36	1.8	0.18	0.05
Cash Growth	-14.78%	-24.06%	898.49%	296.21%	348.86%
Prepaid Expenses	0.03	0.05	0.15	-	-
Other Current Assets	-	-	-	0.19	-
Total Current Assets	1.19	1.41	1.94	0.37	0.05
Total Assets	1.19	1.41	1.94	0.37	0.05
Accounts Payable	0.08	0.03	0.06	0.21	0
Short-Term Debt	-	-	-	-	0.12
Other Current Liabilities	0	0.01	0.02	-	-
Total Current Liabilities	0.08	0.04	0.09	0.21	0.12
Total Liabilities	0.08	0.04	0.09	0.21	0.12
Common Stock	4.2	4.2	4.18	1.25	0.16
Additional Paid-In Capital	1.66	1.63	1.48	0.79	-
Retained Earnings	-4.83	-4.28	-3.59	-1.88	-0.24
Comprehensive Income & Other	0.09	-0.17	-0.2	-	-0
Shareholders' Equity	1.11	1.37	1.86	0.16	-0.08
Total Liabilities & Equity	1.19	1.41	1.94	0.37	0.05
Total Debt	-	-	-	-	0.12
Net Cash (Debt)	1.16	1.36	1.8	0.18	-0.08
Net Cash Growth	-14.78%	-24.06%	898.49%	-	-
Net Cash Per Share	0.03	0.03	0.04	0.01	-0.00
Filing Date Shares Outstanding	75.74	38.74	48.38	47.85	0.79
Total Common Shares Outstanding	38.74	38.74	48.38	38.51	0.79
Working Capital	1.11	1.37	1.86	0.16	-0.08
Book Value Per Share	0.03	0.04	0.04	0.00	-0.10
Tangible Book Value	1.11	1.37	1.86	0.16	-0.08
Tangible Book Value Per Share	0.03	0.04	0.04	0.00	-0.10

Updated Nov 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.